1Doll CM,Milosevic M,Pintilie M,et al.Estimating hypoxic status in human tumors:A simulation using Eppendorf oxygen probe data in cervical cancer patients [J].Int J Radiat Oncol Biol Phys,2003,55(5):1239-1246.
2Bussink J,Kaanders JH,Strik AM,et al.Effects of nicotinamidc and carbogen on oxygenation in human tumor xenografts measured with luminescence based fiber-optic probes [J].Radiother Oncol,2000,57(1):21-30.
3Le QT,Kovacs MS,Doric MJ,et al.Comparison of the comet assay and the oxygen microelectrode for measuring tumor oxygenation in head-and-neck cancer patients [J].Int J Radiat Oncol Biol Phys,2003,56(2):375-383.
4Krishna MC,English S,Yamada K,et al.Overhauser enhanced magnetic resonance imaging for tumor oximetry:coregistration of tumor anatomy and tissue oxygen concentration [J].Proc Natl Acad Sci USA,2002,99(4):2216-2221.
5Elas M,Williams BB,Parasca A,et al.Quantitative tumor oxymetric images from 4D electron para-magnetic resonance imaging(EPRI):Methodology and comparison with blood oxygen level-dependent(BOLD)MRI [J].Magn Reson Med,2003;49(4):682-691.
6Rajendran JG,Wilson DC,Conrad EU,et al.[(18)F]FMISO and [(18)F]FDG PET imaging in soft tissue sarcomas:correlation of hypoxia,metabolism and VEGF expression [J].Eur J Nucl Med Mol Imaging,2003,30(5):695-704.
7Bentzen L,Keiding S,Nordsmark M,et al.Tumour oxygenation assessed by 18F-fluoromisonidazole PET and polarographic needle electrodes in human soft tissue tumours [J].Radiother Oncol,2003,67(3):339-344.
8Gronroos T,Eskola O,Lehtio K,et al.Pharmaco-kinetics of [18F]FETNIM:a potential hypoxia marker for PET [J].J Nucl Med,2001,42(9):1397-1404.
9an De Wiele C,Versijpt J,Dierckx RA,et al.99mTc labelled HL91 versus computed tomography and biopsy for the visualization of tumour recurrence of squamous head and neck carcinoma [J].Nucl Med Commun,2001,22(3):269-275.
1Cook GJ, Houston S, Barrington SF, et al. 99Tcm labeled HL91 to identify tumor hypoxia: correlation with 18F-FDG. J Nucl Med, 1998, 39: 99-103.
2Van de Wiele C, Versijpt J, Dierckx RA, et al. 99Tcm labeled HL91 versus computed tomography and biopsy for the visualization of tumor recurrence of squamous head and neck carcinoma. Nucl Med Commun, 2001,22: 269-275.
